This inventor holds 1 USPTO granted patent. Top assignee: Wyeth. Active years: 2004.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2004
Title: William Joseph Lennox: Innovator in Therapeutic Compounds
Introduction
William Joseph Lennox is a notable inventor based in Monsey, NY (US). He has made significant contributions to the field of medicinal chemistry, particularly in the development of compounds that target specific receptors in the brain.
Latest Patents
Lennox holds a patent for "Heterocyclylindazole and -azaindazole compounds as 5-hydroxytryptamine-6 ligands." This invention provides a compound of formula I and outlines its use in the therapeutic treatment of disorders related to or affected by the 5-HT6 receptor. His innovative work in this area has the potential to impact various neurological conditions.
Career Highlights
William Joseph Lennox is associated with Wyeth, a prominent pharmaceutical company known for its research and development in healthcare. His role at Wyeth has allowed him to focus on advancing therapeutic solutions that address critical health issues.
Collaborations
Throughout his career, Lennox has collaborated with talented individuals such as Ping Zhou and Derek Cecil Cole. These partnerships have fostered a collaborative environment that enhances the innovation process.
Conclusion
William Joseph Lennox's contributions to the field of medicinal chemistry, particularly through his patent on 5-HT6 receptor ligands, highlight his role as an influential inventor. His work continues to pave the way for advancements in therapeutic treatments.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile